VTAK — Catheter Precision, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-09-27.
Performance
Technicals
Others in Healthcare
Measured signals that fired on VTAK
| date | signal | measured base rate |
|---|---|---|
| 2026-07-06 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-06-24 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2025-12-05 | JENKINS DAVID A Chairman of the Board and CEO | Conversion | 98 | 0.00 | 0 |
| 2025-12-05 | JENKINS DAVID A Chairman of the Board and CEO | Conversion | 12.1K | 0.00 | 0 |
| 2025-12-05 | Caruso James Joseph Director | Conversion | 41 | 0.00 | 0 |
| 2025-12-05 | JENKINS DAVID A Chairman of the Board and CEO | Conversion | 30.8K | 0.00 | 0 |
| 2025-01-29 | COLOMBATTO MARTIN J Director | Open-market sale | 3 | 0.40 | 1 |
| 2024-01-23 | JENKINS DAVID A Executive Chairman and CEO | Open-market purchase | 9.5K | 0.60 | 5.7K |
| 2024-01-22 | JENKINS DAVID A Executive Chairman and CEO | Open-market purchase | 9.5K | 0.43 | 4.1K |
| 2024-01-19 | JENKINS DAVID A Executive Chairman and CEO | Open-market purchase | 8.5K | 0.42 | 3.6K |
| 2024-01-18 | JENKINS DAVID A Executive Chairman and CEO | Open-market purchase | 8.5K | 0.41 | 3.5K |
| 2024-01-16 | JENKINS DAVID A Executive Chairman and CEO | Open-market purchase | 8.5K | 0.39 | 3.3K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 48.1K | 47.7K |
| MILLENNIUM MANAGEMENT LLC | 13.3K | 13.1K |
| JANE STREET GROUP, LLC | 11.5K | 11.4K |
| Tower Research Capital LLC (TRC) | 3.9K | 3.9K |
| UBS Group AG | 767 | 759 |
| Allworth Financial LP | 303 | 300 |
| Virtu Financial LLC | 14 | 13.5K |
| Purpose Unlimited Inc. | 13 | 13 |
| HRT FINANCIAL LP | 11 | 11.3K |
| HARBOUR INVESTMENTS, INC. | 8 | 8 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-07-31 | 2026-07-27 | on EDGAR ↗ |
| 8-K/A | 2026-07-29 | 2026-03-09 | on EDGAR ↗ |
| SCHEDULE 13G | 2026-07-20 | — | on EDGAR ↗ |
| 8-K | 2026-07-15 | 2026-07-14 | on EDGAR ↗ |
| EFFECT | 2026-07-10 | — | on EDGAR ↗ |
| 424B3 | 2026-07-10 | — | on EDGAR ↗ |
| S-1/A | 2026-07-06 | — | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Catheter Precision, Inc. (VTAK) filed form 10-Q · 2026-08-14 · SEC EDGAR
Ask the AI about VTAK
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →